Clinical study of Hongai Tongluo decoction combined with Du moxibustion in the treatment of Oxaliplatin Neurotoxicity

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000003629

Enrollment

Unknown

Registered

2020-08-22

Start date

2020-10-08

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive tract tumor

Interventions

control group:Chemotherapy

experimental group: Hongai Tongluo decoction combined with Du moxibustion and chemotherapy

Eligibility

Sex/Gender

All

Age

17 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. All patients were diagnosed as gastric cancer or colorectal cancer by pathology, and the pathological types were not limited; 2. Oxaliplatin chemotherapy was used for the first time. 3. The ECG, blood routine, urine routine, liver and kidney function were basically normal. Karnofsky score (KPS) >= 70; 4. The expected survival time was more than 3 months.

Exclusion criteria

Exclusion criteria: Patients with nervous system diseases such as cerebrovascular disease, diabetic peripheral neuropathy, patients who are being treated with other chemotherapy drugs that may cause neurotoxicity, patients with hand foot skin lesions or history of drug allergy.

Design outcomes

Primary

Measure	Time frame
Liver and kidney function;routine blood test;electromyogram;	—

Countries

China

Contacts

Public ContactYao Qiong

Shanghai Longhua University Hospital of Traditional Chinese Medicine

ethan-yao@126.com+86 13817103927

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026